Lysosome and proteasome dysfunction in alcohol-induced liver injury

Terrence M. Donohue, Natalia A. Osna, Kusum K. Kharbanda, Paul G. Thomes

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The review describes research findings on the influence of alcohol consumption on two crucial catabolic systems in hepatocytes: the lysosome and the ubiquitin-proteasome system (UPS). The lysosome is a membrane-bound organelle that degrades all aging and/or damaged organelles and hydrolyzes all forms of macromolecules. The UPS is mostly proteolytic. It carries out the majority of its functions in the soluble portion of the cytoplasm (cytosol) and degrades nearly all intracellular proteins, particularly those with short half-lives, so that their levels are tightly controlled. Our review will briefly discuss the epidemiology of alcohol abuse and the spectrum of alcohol-induced liver disease (AILD). We will explain why ethanol (EtOH) metabolism, but not EtOH alone, is hepatotoxic. Then, we will summarize how heavy drinking alters hepatic catabolic systems, resulting in liver enlargement that develops from hepatocyte swelling due, in part, to aberrant accumulation of undegraded lipid droplets (steatosis) and undegraded proteins (proteopathy). Our detailed description of each catabolic system will highlight its discoverer(s) and emphasize each system's characteristics. Most important, we will review the evidence that chronic EtOH consumption disrupts hepatic lysosome biogenesis and inhibits the UPS by impeding hepatic proteasome activity. It will become evident that each of these EtOH-induced defects has far-reaching functional consequences. Finally, we will describe current and potential therapeutic interventions for alleviating EtOH-induced liver injury. The most effective intervention is the cessation of EtOH consumption. However, there are other potential approaches using natural or synthetic compounds that activate autophagy or the proteasome to enhance the degradation of accumulated lipid droplets or proteins, respectively, which could alleviate AILD. These approaches, now in their early stages of investigation, will also be discussed in this review.

Original languageEnglish (US)
Pages (from-to)191-205
Number of pages15
JournalLiver Research
Volume3
Issue number3-4
DOIs
StatePublished - Dec 2019

Fingerprint

Proteasome Endopeptidase Complex
Lysosomes
Alcohols
Ubiquitin
Liver
Wounds and Injuries
Organelles
Liver Diseases
Hepatocytes
Autophagy
Alcohol Drinking
Cytosol
Alcoholism
Drinking
Cytoplasm
Epidemiology
Proteins
Ethanol
Membranes
Research

Keywords

  • Alcohol
  • Alcohol-induced liver disease (AILD)
  • Ethanol
  • Lipostasis
  • Liver
  • Lysosome
  • Proteasome
  • Proteostasis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Lysosome and proteasome dysfunction in alcohol-induced liver injury. / Donohue, Terrence M.; Osna, Natalia A.; Kharbanda, Kusum K.; Thomes, Paul G.

In: Liver Research, Vol. 3, No. 3-4, 12.2019, p. 191-205.

Research output: Contribution to journalReview article

Donohue, Terrence M. ; Osna, Natalia A. ; Kharbanda, Kusum K. ; Thomes, Paul G. / Lysosome and proteasome dysfunction in alcohol-induced liver injury. In: Liver Research. 2019 ; Vol. 3, No. 3-4. pp. 191-205.
@article{df9a6c17193645bf9ae5c01ae2ffc15f,
title = "Lysosome and proteasome dysfunction in alcohol-induced liver injury",
abstract = "The review describes research findings on the influence of alcohol consumption on two crucial catabolic systems in hepatocytes: the lysosome and the ubiquitin-proteasome system (UPS). The lysosome is a membrane-bound organelle that degrades all aging and/or damaged organelles and hydrolyzes all forms of macromolecules. The UPS is mostly proteolytic. It carries out the majority of its functions in the soluble portion of the cytoplasm (cytosol) and degrades nearly all intracellular proteins, particularly those with short half-lives, so that their levels are tightly controlled. Our review will briefly discuss the epidemiology of alcohol abuse and the spectrum of alcohol-induced liver disease (AILD). We will explain why ethanol (EtOH) metabolism, but not EtOH alone, is hepatotoxic. Then, we will summarize how heavy drinking alters hepatic catabolic systems, resulting in liver enlargement that develops from hepatocyte swelling due, in part, to aberrant accumulation of undegraded lipid droplets (steatosis) and undegraded proteins (proteopathy). Our detailed description of each catabolic system will highlight its discoverer(s) and emphasize each system's characteristics. Most important, we will review the evidence that chronic EtOH consumption disrupts hepatic lysosome biogenesis and inhibits the UPS by impeding hepatic proteasome activity. It will become evident that each of these EtOH-induced defects has far-reaching functional consequences. Finally, we will describe current and potential therapeutic interventions for alleviating EtOH-induced liver injury. The most effective intervention is the cessation of EtOH consumption. However, there are other potential approaches using natural or synthetic compounds that activate autophagy or the proteasome to enhance the degradation of accumulated lipid droplets or proteins, respectively, which could alleviate AILD. These approaches, now in their early stages of investigation, will also be discussed in this review.",
keywords = "Alcohol, Alcohol-induced liver disease (AILD), Ethanol, Lipostasis, Liver, Lysosome, Proteasome, Proteostasis",
author = "Donohue, {Terrence M.} and Osna, {Natalia A.} and Kharbanda, {Kusum K.} and Thomes, {Paul G.}",
year = "2019",
month = "12",
doi = "10.1016/j.livres.2019.11.001",
language = "English (US)",
volume = "3",
pages = "191--205",
journal = "Liver Research",
issn = "2542-5684",
number = "3-4",

}

TY - JOUR

T1 - Lysosome and proteasome dysfunction in alcohol-induced liver injury

AU - Donohue, Terrence M.

AU - Osna, Natalia A.

AU - Kharbanda, Kusum K.

AU - Thomes, Paul G.

PY - 2019/12

Y1 - 2019/12

N2 - The review describes research findings on the influence of alcohol consumption on two crucial catabolic systems in hepatocytes: the lysosome and the ubiquitin-proteasome system (UPS). The lysosome is a membrane-bound organelle that degrades all aging and/or damaged organelles and hydrolyzes all forms of macromolecules. The UPS is mostly proteolytic. It carries out the majority of its functions in the soluble portion of the cytoplasm (cytosol) and degrades nearly all intracellular proteins, particularly those with short half-lives, so that their levels are tightly controlled. Our review will briefly discuss the epidemiology of alcohol abuse and the spectrum of alcohol-induced liver disease (AILD). We will explain why ethanol (EtOH) metabolism, but not EtOH alone, is hepatotoxic. Then, we will summarize how heavy drinking alters hepatic catabolic systems, resulting in liver enlargement that develops from hepatocyte swelling due, in part, to aberrant accumulation of undegraded lipid droplets (steatosis) and undegraded proteins (proteopathy). Our detailed description of each catabolic system will highlight its discoverer(s) and emphasize each system's characteristics. Most important, we will review the evidence that chronic EtOH consumption disrupts hepatic lysosome biogenesis and inhibits the UPS by impeding hepatic proteasome activity. It will become evident that each of these EtOH-induced defects has far-reaching functional consequences. Finally, we will describe current and potential therapeutic interventions for alleviating EtOH-induced liver injury. The most effective intervention is the cessation of EtOH consumption. However, there are other potential approaches using natural or synthetic compounds that activate autophagy or the proteasome to enhance the degradation of accumulated lipid droplets or proteins, respectively, which could alleviate AILD. These approaches, now in their early stages of investigation, will also be discussed in this review.

AB - The review describes research findings on the influence of alcohol consumption on two crucial catabolic systems in hepatocytes: the lysosome and the ubiquitin-proteasome system (UPS). The lysosome is a membrane-bound organelle that degrades all aging and/or damaged organelles and hydrolyzes all forms of macromolecules. The UPS is mostly proteolytic. It carries out the majority of its functions in the soluble portion of the cytoplasm (cytosol) and degrades nearly all intracellular proteins, particularly those with short half-lives, so that their levels are tightly controlled. Our review will briefly discuss the epidemiology of alcohol abuse and the spectrum of alcohol-induced liver disease (AILD). We will explain why ethanol (EtOH) metabolism, but not EtOH alone, is hepatotoxic. Then, we will summarize how heavy drinking alters hepatic catabolic systems, resulting in liver enlargement that develops from hepatocyte swelling due, in part, to aberrant accumulation of undegraded lipid droplets (steatosis) and undegraded proteins (proteopathy). Our detailed description of each catabolic system will highlight its discoverer(s) and emphasize each system's characteristics. Most important, we will review the evidence that chronic EtOH consumption disrupts hepatic lysosome biogenesis and inhibits the UPS by impeding hepatic proteasome activity. It will become evident that each of these EtOH-induced defects has far-reaching functional consequences. Finally, we will describe current and potential therapeutic interventions for alleviating EtOH-induced liver injury. The most effective intervention is the cessation of EtOH consumption. However, there are other potential approaches using natural or synthetic compounds that activate autophagy or the proteasome to enhance the degradation of accumulated lipid droplets or proteins, respectively, which could alleviate AILD. These approaches, now in their early stages of investigation, will also be discussed in this review.

KW - Alcohol

KW - Alcohol-induced liver disease (AILD)

KW - Ethanol

KW - Lipostasis

KW - Liver

KW - Lysosome

KW - Proteasome

KW - Proteostasis

UR - http://www.scopus.com/inward/record.url?scp=85076253622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076253622&partnerID=8YFLogxK

U2 - 10.1016/j.livres.2019.11.001

DO - 10.1016/j.livres.2019.11.001

M3 - Review article

AN - SCOPUS:85076253622

VL - 3

SP - 191

EP - 205

JO - Liver Research

JF - Liver Research

SN - 2542-5684

IS - 3-4

ER -